Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

16.04
Delayed Data
As of 3:59pm ET
 +0.04 / +0.25%
Today’s Change
12.45
Today|||52-Week Range
20.65
-19.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues104.6M126.4M105.6M120.8M
 
 
 
 
 
Cost of Goods Sold73.3M84.1M70.8M74.5M
 
 
 
 
 
Depreciation And Amortization6.9M8.4M8.5M7.8M
 
 
 
 
 
 
Operating ExpensesGross Income24.4M33.9M26.2M38.6M
 
 
 
 
 
General Expenses23.1M24.9M27.8M31.4M
 
 
 
 
 
Research And Development1.9M2.7M3.2M3.5M
 
 
 
 
 
Total Operating Expenses103.3M117.4M107.1M113.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.3M9.0M-1.6M7.2M
 
 
 
 
 
Extraordinary Charge-1.2M-2.8M-2.6M-7.1M
 
 
 
 
 
Interest Expense On Debt6.3M6.8M7.1M7.1M
 
 
 
 
 
Other Expenses798.0K319.0K-997.0K740.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.5M-245.0K-12.3M-6.3M
 
 
 
 
 
Income Taxes-1.3M-2.0M-2.2M-15.0M
 
 
 
 
 
Net Income-4.2M1.8M-10.1M-21.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.1M35.6M34.7M34.9M
 
 
 
 
 
Shares To Calculate EPS Diluted34.1M35.6M34.7M34.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12$0.05-$0.29-$0.61
 
 
 
 
 
EPS Diluted-$0.12$0.05-$0.29-$0.61